XNAS · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
Moderna (MRNA) had 1 Form 144 pre-sale notice filed on 2026-05-15. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing refe…
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 5/6/2026 | AFEYAN NOUBAR | — | GRANT | 12,908 | — | — |
| 5/6/2026 | Tallett Elizabeth E | — | GRANT | 8,371 | — | — |
| 5/6/2026 | Nader Francois | — | GRANT | 4,185 | — | — |
| 5/6/2026 | Nader Francois | — | GRANT | 6,454 | — | — |
| 5/6/2026 | NABEL ELIZABETH G | — | GRANT | 8,371 | — | — |
| 5/6/2026 | Horning Sandra | — | GRANT | 2,092 | — | — |
| 5/6/2026 | Horning Sandra | — | GRANT | 9,681 | — | — |
| 5/6/2026 | Hussain Abbas | — | GRANT | 8,371 | — | — |
| 5/6/2026 | Rubenstein David M. | — | GRANT | 2,092 | — | — |
| 5/6/2026 | Rubenstein David M. | — | GRANT | 9,681 | — | — |
| 5/1/2026 | Hussain Abbas | — | SELL | -5,682 | $47 | $264,952 |
| 4/30/2026 | Tallett Elizabeth E | — | OPTION_EXERCISE | -4,058 | — | — |
| 4/30/2026 | Tallett Elizabeth E | — | OPTION_EXERCISE | 4,058 | — | — |
| 4/30/2026 | Nader Francois | — | OPTION_EXERCISE | -12,174 | — | — |
| 4/30/2026 | Nader Francois | — | OPTION_EXERCISE | 12,174 | — | — |
| 4/30/2026 | NABEL ELIZABETH G | — | OPTION_EXERCISE | -16,233 | — | — |
| 4/30/2026 | NABEL ELIZABETH G | — | OPTION_EXERCISE | 16,233 | — | — |
| 4/30/2026 | Hussain Abbas | — | OPTION_EXERCISE | -16,233 | — | — |
| 4/30/2026 | Hussain Abbas | — | OPTION_EXERCISE | 16,233 | — | — |
| 4/30/2026 | Rubenstein David M. | — | OPTION_EXERCISE | -8,116 | — | — |